Covaxin | Brazil
Brazil suspends $324 million contract to buy Bharat Biotech's Covaxin doses
New Delhi/IBNS: Brazil has announced the suspension of the $324 million contract to buy 20 million doses of Bharat Biotech's anti-COVID-19 vaccine, Covaxin, media reports said.
The announcement has been made by the country's Health Minister Marcelo Queiroga and head of the Federal Comptroller General (CGU) Wagner Rosario.
Bharat Biotech is Hyderabad-based biotechnology company in India.
The suspension comes amid a probe into Brazil President Jair Bolsonaro's alleged irregularities in the deal which was signed in Feb this year.
The country's Senate is probing into the deal between the Bolsonaro government and broker Need Medicines.
Countering the charge, Bolsonaro said the Senate is trying to undermine his administration.
Meanwhile, Bharat Biotech on Wednesday said it has not received any advance payment from Brazil.
"Emergency use authorisation received on 4 June. As of 29 June, Bharat Biotech has not received any advance payments nor supplied any vaccines to Brazil," Bharat Biotech said in a statement.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
